Selected data models

You must log in to select data models for download or further analysis.

7 Search results.
Relevance Rating New first Old first

Eligibility Knee Pain Chronic NCT01345123

- 6/14/20 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Supporting Decision Making for Musculoskeletal Preference-Sensitive Care; ODM derived from: https://clinicaltrials.gov/show/NCT01345123

Evaluation of Naproxen Sodium and Sumatriptan in Adolescent Subjects With Migraine and Healthy Adult Subjects NCT00989625 - Screen - Eligibility Question

- 8/8/19 - 1 form, 6 itemgroups, 6 items, 1 language
Itemgroups: Date of visit/assessment, Eligibility Question, Inclusion Criteria, Exclusion Criteria, Inclusion Criteria ADOLESCENTS ONLY, Exclusion Criteria ADOLESCENTS ONLY
Study ID: 108504 Clinical Study ID: 108504 Study Title: An Open Label, Single Dose, Randomised, Parallel Group Pharmacokinetic Study to Evaluate a Combination Product Containing Naproxen Sodium and Sumatriptan in Adolescent Subjects With Migraine and Healthy Adult Subjects Administered at Three Doses. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00989625 Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: This is a pharmacokinetic study (Treximet) Trade Name: Naproxen Sodium and Sumatriptan Study Indication: Migraine Disorders

Eligibility Pain NCT01119885

- 8/15/18 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Observational Study Investigating the Effectiveness of Fentanyl Matrix in Relieving Pain and Improving Function in Patients With Osteoarthritis of the Knee or Hip; ODM derived from: https://clinicaltrials.gov/show/NCT01119885

Eligibility Neuropathic Pain NCT02246712

- 7/12/18 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Influence of Diabetes on Tramadol Pharmacokinetics; ODM derived from: https://clinicaltrials.gov/show/NCT02246712

Eligibility Pain NCT00980798

- 8/21/17 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Placebo-controlled Trial With OROS Hydromorphone Hydrochloride to Treat Patients With Moderate to Severe Pain Induced by Osteoarthritis of the Hip or the Knee; ODM derived from: https://clinicaltrials.gov/show/NCT00980798

Eligibility Pain NCT00404183

- 11/18/16 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR)and Placebo in Subjects With Osteoarthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00404183

Eligibility Tourniquet-induced Pain NCT01441531

- 3/13/16 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy of Gabapentin in Prevention of Tourniquet Pain and Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01441531

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial